Hirai Y, Sakurai J, Yoshida S, Kikuchi T, et al. Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma. J Dermatol 2024 Jun 14. doi: 10.1111/1346-8138.17324.
PMID: 38874430